Market Cap 205.78M
Revenue (ttm) 1.55M
Net Income (ttm) -63.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,068.39%
Debt to Equity Ratio 0.00
Volume 2,015,500
Avg Vol 2,221,808
Day's Range N/A - N/A
Shares Out 119.64M
Stochastic %K 20%
Beta 1.04
Analysts Strong Sell
Price Target $6.50

Company Profile

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a...

Industry: Biotechnology
Sector: Healthcare
Phone: 514 336 0444
Address:
1111 Dr. Frederik-Philips Boulevard, Suite 420, Montreal, Canada
Mideo
Mideo May. 15 at 9:09 PM
$MIST Google RTW investments and watch a couple of videos. Sharp guy and huge investor in this.
0 · Reply
Ga_glovo
Ga_glovo May. 15 at 8:08 PM
$MIST hard to say but this goes back to 1.0, tough it will never fall again below 2.0
1 · Reply
Diverstj981
Diverstj981 May. 15 at 7:59 PM
$MIST Added another 10k at the close. 243.3k total.
2 · Reply
Bcoin777
Bcoin777 May. 15 at 6:28 PM
$MIST thank the analyst for the price drop
0 · Reply
Bcoin777
Bcoin777 May. 15 at 6:15 PM
$MIST year tp date 600 scripts
0 · Reply
CashisKing_
CashisKing_ May. 15 at 5:39 PM
$MIST im just going to say this once….this is mentally exhausting
1 · Reply
Joe_BLow_88
Joe_BLow_88 May. 15 at 4:50 PM
$MIST Interesting how the management and adage release the mediocre ER and bad news (Shelf+warrant notice) all at once. Interesting....maybe a good buy opportunity for long termers willing to ride the roller coaster and play the ups and downs? This stock is reasonably predictable at this point, provided you have a bloomberg terminal to track prescription numbers.
1 · Reply
alexpitti
alexpitti May. 15 at 3:40 PM
perfect day to talk to $MIST ceo because they are getting hit
1 · Reply
AP1810
AP1810 May. 15 at 2:32 PM
$MIST Man HC Wainwright is looking really stupid with this pick…. This turd drops 5-10% a day…. Yikes!
1 · Reply
JanetBSmellin
JanetBSmellin May. 15 at 2:18 PM
$MIST It more than doubled and is now 50% higher since this post. Why are you here?🤡
1 · Reply
Latest News on MIST
Milestone Pharmaceuticals files $300M mixed securities shelf

2026-05-13T21:54:39.000Z - 2 days ago

Milestone Pharmaceuticals files $300M mixed securities shelf


Milestone Pharmaceuticals Earnings Call Transcript: Q1 2026

May 13, 2026, 8:30 AM EDT - 2 days ago

Milestone Pharmaceuticals Earnings Call Transcript: Q1 2026


Milestone Pharmaceuticals Earnings Call Transcript: Q4 2025

Mar 20, 2026, 8:30 AM EDT - 2 months ago

Milestone Pharmaceuticals Earnings Call Transcript: Q4 2025


Milestone Pharmaceuticals reports Q4 EPS (16c), consensus (18c)

2026-03-20T11:21:41.000Z - 2 months ago

Milestone Pharmaceuticals reports Q4 EPS (16c), consensus (18c)


Milestone Pharmaceuticals to present Cardamyst data at ACC 26

2026-03-16T12:23:37.000Z - 2 months ago

Milestone Pharmaceuticals to present Cardamyst data at ACC 26


Milestone Pharmaceuticals upgraded to Buy from Hold at TD Cowen

2025-12-15T15:05:16.000Z - 5 months ago

Milestone Pharmaceuticals upgraded to Buy from Hold at TD Cowen


Milestone Pharmaceuticals Transcript: FDA Announcement

Dec 15, 2025, 8:00 AM EST - 5 months ago

Milestone Pharmaceuticals Transcript: FDA Announcement


Milestone Pharmaceuticals receives FDA approval of CARDAMYST

2025-12-14T16:30:25.000Z - 5 months ago

Milestone Pharmaceuticals receives FDA approval of CARDAMYST


Milestone® Pharmaceuticals to Present at Upcoming Conferences

Aug 19, 2025, 8:00 AM EDT - 9 months ago

Milestone® Pharmaceuticals to Present at Upcoming Conferences


Milestone Pharmaceuticals Announces Proposed Public Offering

Jul 11, 2025, 6:01 AM EDT - 11 months ago

Milestone Pharmaceuticals Announces Proposed Public Offering


FDA Issues Complete Response Letter for Etripamil for PSVT

Mar 28, 2025, 7:00 AM EDT - 1 year ago

FDA Issues Complete Response Letter for Etripamil for PSVT


Milestone Pharmaceuticals Transcript: Investor update

Feb 25, 2025, 10:30 AM EST - 1 year ago

Milestone Pharmaceuticals Transcript: Investor update


Milestone Pharmaceuticals Transcript: Study update

Jun 20, 2024, 8:00 AM EDT - 2 years ago

Milestone Pharmaceuticals Transcript: Study update


Mideo
Mideo May. 15 at 9:09 PM
$MIST Google RTW investments and watch a couple of videos. Sharp guy and huge investor in this.
0 · Reply
Ga_glovo
Ga_glovo May. 15 at 8:08 PM
$MIST hard to say but this goes back to 1.0, tough it will never fall again below 2.0
1 · Reply
Diverstj981
Diverstj981 May. 15 at 7:59 PM
$MIST Added another 10k at the close. 243.3k total.
2 · Reply
Bcoin777
Bcoin777 May. 15 at 6:28 PM
$MIST thank the analyst for the price drop
0 · Reply
Bcoin777
Bcoin777 May. 15 at 6:15 PM
$MIST year tp date 600 scripts
0 · Reply
CashisKing_
CashisKing_ May. 15 at 5:39 PM
$MIST im just going to say this once….this is mentally exhausting
1 · Reply
Joe_BLow_88
Joe_BLow_88 May. 15 at 4:50 PM
$MIST Interesting how the management and adage release the mediocre ER and bad news (Shelf+warrant notice) all at once. Interesting....maybe a good buy opportunity for long termers willing to ride the roller coaster and play the ups and downs? This stock is reasonably predictable at this point, provided you have a bloomberg terminal to track prescription numbers.
1 · Reply
alexpitti
alexpitti May. 15 at 3:40 PM
perfect day to talk to $MIST ceo because they are getting hit
1 · Reply
AP1810
AP1810 May. 15 at 2:32 PM
$MIST Man HC Wainwright is looking really stupid with this pick…. This turd drops 5-10% a day…. Yikes!
1 · Reply
JanetBSmellin
JanetBSmellin May. 15 at 2:18 PM
$MIST It more than doubled and is now 50% higher since this post. Why are you here?🤡
1 · Reply
Newmoves
Newmoves May. 15 at 11:28 AM
$MIST when are they raising money and when is dilution? Back to a dollar?
3 · Reply
Diverstj981
Diverstj981 May. 15 at 11:26 AM
$MIST Getting close to time to add more here. I'm not expecting it to dip as low as it did in late March but there's still a bit more downside coming first IMO. I'm ready and waiting. 233.3k shares and counting.
1 · Reply
trendsetter20
trendsetter20 May. 15 at 11:00 AM
$MIST Are you rational or emotional ? If you are emotional, and saying the sky is falling, you should hand your portfolio off to someone else to manage. If you are rational, you will understand that the smart money has a) started to exercise warrants that expire July 14th by selling and buying across the spread and b) 8M warrants is not very much in dollar terms and it is likely that most warrants will have been taken up by institutions, market makers (and myself) over the next 30 days and then the stock will pop back above $2. The exercise will have bought in more cash. More cash is also likely coming in in Q3 and sales will gradually expand over time. The bears will get trapped and the emotional ones will lose their money. It is that simple.
1 · Reply
Newmoves
Newmoves May. 15 at 1:03 AM
$MIST sales team is struggling to sell this to doctors patients don’t want to buy this. too much of a niche product. this is only rescue therapy. 
1 · Reply
Bcoin777
Bcoin777 May. 14 at 10:20 PM
$MIST what figures are analyst going to come out with for july 12 2026 earnings call they will exagerate a number to bring the stock price down again like they did this first quarter.
0 · Reply
Bcoin777
Bcoin777 May. 14 at 10:17 PM
$MIST cant't believe anything that analyst say where did they come up with 56 million in revenue
0 · Reply
Pszemsss
Pszemsss May. 14 at 8:17 PM
$MIST STRONG BUY
0 · Reply
BiotekInvestor
BiotekInvestor May. 14 at 5:33 PM
$MIST Nobody wants to be caught holding the bag in July when those warrants get exercised. I would be happy if the share price stayed between 1.50-1.60 until the end of July. After that, if sales numbers can improve, it’ll start crawling back above 2.00.
3 · Reply
TheYoungGeologist
TheYoungGeologist May. 14 at 3:36 PM
$MIST back to the shelf offering, I'm assuming this is in preparedness for A-fib trial funding as cash runway for normal operations is through 2027
2 · Reply
Rroper
Rroper May. 14 at 2:49 PM
$MIST Back down we go. Always sell on no news pops. 80/20 rule on that.
1 · Reply
Diverstj981
Diverstj981 May. 14 at 1:59 PM
$MIST What we're seeing today is pecisely why I didn't BTD in the 13th. Action here is becoming very predictable, which creates great opportunities to trade around a core position and be well paid to wait for Q4 '26 and Q1 '27 when we launch.
0 · Reply
soccerfan913
soccerfan913 May. 14 at 1:56 PM
$MIST This stock really tests the patience. Management can't seem to say anything without destroying shareholder value. It creeps up 2 or 3 cents and then management speaks and it drops 20%.
3 · Reply